Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

Description

There is on-going development of  generic EU CTD Dossier of Risedronate, tablets, 5/30/35 mg.


Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Risedronic acid (INN) or risedronate sodium (USAN, trade name Actonel) is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone.

More details at: http://www.rxlist.com/actonel-drug.htm.

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 41

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

I’m a representative of Parafarm (Penza,...
406 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
342 Views
Profitable and Modern Russian CMO with long...
324 Views
Adalimumab API available: - from EU cGMP...
10027 Views
Infliximab API available: - from EU cGMP...
343 Views
Normal 0 false false false EN-US X-NONE HE /*...
334 Views
Start-up pharmaceutical company from South...
1679 Views